A Bioequivalence Study Of Ibuprofen 50mg/ml (laboratórios Pfizer Ltda) In The Oral Suspension Form.
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
An open label, randomized, 2x2 crossover, single dose, phase 4 study to determine the
pharmaceutical bioequivalence of ibuprofen 50mg/ml (laboratórios pfizer ltda) oral suspension
versus alivium ® 50mg/ml (mantecorp indústria química e farmacêutica ltda.) Oral suspension,
in healthy fasting volunteers.